Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105135374 | 10513537 | 4 | F | 20160505 | 20160712 | 20141013 | 20160725 | PER | US-PFIZER INC-2014280581 | PFIZER | 58.00 | YR | F | Y | 86.17000 | KG | 20160725 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105135374 | 10513537 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 2X/DAY | 21446 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 105135374 | 10513537 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 2X/DAY | 21446 | 200 | MG | CAPSULE, HARD | BID | ||||||
| 105135374 | 10513537 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 2X/DAY | 21446 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 105135374 | 10513537 | 4 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 105135374 | 10513537 | 5 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 105135374 | 10513537 | 6 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 105135374 | 10513537 | 7 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 60 MG, 1X/DAY | 0 | 60 | MG | TABLET | QD | ||||||
| 105135374 | 10513537 | 8 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 60 MG, DAILY (40 MG 1 1/2 TABS) | 0 | 60 | MG | TABLET | ||||||||
| 105135374 | 10513537 | 9 | C | TRILEPTAL | OXCARBAZEPINE | 1 | 600MG TABLET 1/2 IN THE MORNING AND A WHOLE IN THE EVENING | 0 | TABLET | BID | |||||||||
| 105135374 | 10513537 | 10 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0.5 MG, AS NEEDED (3 TIMES A DAY ) | 0 | .5 | MG | TABLET | |||||||
| 105135374 | 10513537 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 1 MG, AS NEEDED | 0 | 1 | MG | TABLET | ||||||||
| 105135374 | 10513537 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | ||||||
| 105135374 | 10513537 | 13 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, 2X/DAY | 0 | 10 | MG | TABLET | BID | ||||||
| 105135374 | 10513537 | 14 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 105135374 | 10513537 | 15 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | TABLET | |||||||||||
| 105135374 | 10513537 | 16 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 30 MG, 1X/DAY (BED TIME) | 0 | 30 | MG | QD | ||||||||
| 105135374 | 10513537 | 17 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 30 MG, AS NEEDED (QHS PRN) | 0 | 30 | MG | |||||||||
| 105135374 | 10513537 | 18 | C | ZIPRASIDONE. | ZIPRASIDONE | 1 | 40 MG, 2X/DAY | 0 | 40 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105135374 | 10513537 | 1 | Back pain |
| 105135374 | 10513537 | 2 | Sciatica |
| 105135374 | 10513537 | 3 | Spinal disorder |
| 105135374 | 10513537 | 4 | Spinal osteoarthritis |
| 105135374 | 10513537 | 5 | Osteoarthritis |
| 105135374 | 10513537 | 6 | Depression |
| 105135374 | 10513537 | 7 | Bipolar disorder |
| 105135374 | 10513537 | 9 | Affective disorder |
| 105135374 | 10513537 | 10 | Anxiety |
| 105135374 | 10513537 | 12 | Blood cholesterol increased |
| 105135374 | 10513537 | 13 | Hypertension |
| 105135374 | 10513537 | 14 | Blood pressure abnormal |
| 105135374 | 10513537 | 15 | Hypertension |
| 105135374 | 10513537 | 16 | Mood altered |
| 105135374 | 10513537 | 17 | Insomnia |
| 105135374 | 10513537 | 18 | Mood altered |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105135374 | 10513537 | Influenza like illness | |
| 105135374 | 10513537 | Intentional product misuse | |
| 105135374 | 10513537 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |